Skip to main content
Livermore
Livermore
ZHEN

Svennilson Peter's Form 4 filing

Eikon Therapeutics, Inc. (EIKN) · filed Feb 9, 2026

Accession no.
0001193125-26-043320
Filed
Feb 9, 2026, 9:19 PM ET
Trade date
Feb 6, 2026
Filing delay
3 days
Rule 10b5-1 plan
Not checked

This filing lists 10 non-derivative transactions and 7 derivative transactions. Open-market purchases total $38.1M. It was filed 3 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Svennilson PeterCIK 000160607410% Owner
Kutzkey TimCIK 000161418610% Owner
Column Group IV-A, LPCIK 000179635310% Owner
Column Group IV, LPCIK 000179635410% Owner
Column Group IV GP, LPCIK 000179635610% Owner
Column Group Opportunity III, LPCIK 000193182510% Owner
TCG Opportunity III GP, LLCCIK 000193244510% Owner
Column Group Opportunity III GP, LPCIK 000193287410% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 6, 2026Common StockCConversionAcquired+1,296,629–F1–1,360,320Indirect
Feb 6, 2026Common StockCConversionAcquired+1,403,568–F1–2,763,888Indirect
Feb 6, 2026Common StockCConversionAcquired+110,928–F1–2,874,816Indirect
Feb 6, 2026Common StockCConversionAcquired+44,249–F1–47,601Indirect
Feb 6, 2026Common StockCConversionAcquired+47,898–F1–95,499Indirect
Feb 6, 2026Common StockCConversionAcquired+3,785–F1–99,284Indirect
Feb 6, 2026Common StockCConversionAcquired+688,283–F1–688,283Indirect
Feb 6, 2026Common StockPPurchaseAcquired+1,437,323$18.00+$25,871,8144,312,139Indirect
Feb 6, 2026Common StockPPurchaseAcquired+49,556$18.00+$892,008148,840Indirect
Feb 6, 2026Common StockPPurchaseAcquired+630,881$18.00+$11,355,8581,319,164Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 6, 2026Common StockCConversionDisposed−1,296,629–F1–0Indirect
Feb 6, 2026Common StockCConversionDisposed−44,249–F1–0Indirect
Feb 6, 2026Common StockCConversionDisposed−1,403,568–F1–0Indirect
Feb 6, 2026Common StockCConversionDisposed−47,898–F1–0Indirect
Feb 6, 2026Common StockCConversionDisposed−110,928–F1–0Indirect
Feb 6, 2026Common StockCConversionDisposed−3,785–F1–0Indirect
Feb 6, 2026Common StockCConversionDisposed−688,283–F1–0Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of the Issuer's Common Stock and has no expiration date

Referenced by the price of 7 transactions in Table I and 7 transactions in Table II.

Read the full filing on SEC EDGAR (opens in a new tab)